CME Payout Ratio vs Payables Turnover Analysis
CME Stock | USD 237.33 2.94 1.25% |
CME financial indicator trend analysis is way more than just evaluating CME Group prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether CME Group is a good investment. Please check the relationship between CME Payout Ratio and its Payables Turnover accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
Payout Ratio vs Payables Turnover
Payout Ratio vs Payables Turnover Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of CME Group Payout Ratio account and Payables Turnover. At this time, the significance of the direction appears to have no relationship.
The correlation between CME's Payout Ratio and Payables Turnover is 0.09. Overlapping area represents the amount of variation of Payout Ratio that can explain the historical movement of Payables Turnover in the same time period over historical financial statements of CME Group, assuming nothing else is changed. The correlation between historical values of CME's Payout Ratio and Payables Turnover is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Payout Ratio of CME Group are associated (or correlated) with its Payables Turnover. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Payables Turnover has no effect on the direction of Payout Ratio i.e., CME's Payout Ratio and Payables Turnover go up and down completely randomly.
Correlation Coefficient | 0.09 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Payout Ratio
Payout Ratio is the proportion of CME Group earnings paid out as dividends to shareholders. Payout Ratio is typically expressed as a percentage but can be shown as dividends paid out as a proportion of cash flow. The payout ratio is used to determine the sustainability of CME Group dividend payments. A lower payout ratio is generally preferable to a higher payout ratio, with a ratio greater than 100% indicating CME Group is paying out more in dividends than it makes in net income.Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Most indicators from CME's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CME Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. At present, CME's Enterprise Value is projected to increase significantly based on the last few years of reporting.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 3.9B | 4.3B | 4.5B | 2.5B | Total Revenue | 4.7B | 5.0B | 5.6B | 3.0B |
CME fundamental ratios Correlations
Click cells to compare fundamentals
CME Account Relationship Matchups
High Positive Relationship
High Negative Relationship
CME fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 75.2B | 124.7B | 196.8B | 174.2B | 129.7B | 136.2B | |
Short Long Term Debt Total | 3.8B | 3.5B | 3.4B | 3.4B | 3.9B | 3.7B | |
Other Current Liab | 38.5B | 88.1B | 159.6B | 137.5B | 93.3B | 97.9B | |
Total Current Liabilities | 38.5B | 88.2B | 160.4B | 137.7B | 93.4B | 98.1B | |
Total Stockholder Equity | 26.1B | 26.3B | 27.4B | 26.9B | 26.7B | 17.6B | |
Other Liab | 6.2B | 6.7B | 6.3B | 5.7B | 6.6B | 6.2B | |
Property Plant And Equipment Net | 544M | 579.2M | 505.3M | 455.5M | 744.3M | 486.3M | |
Net Debt | 2.2B | 1.8B | 610.2M | 718.3M | 971.9M | 843.8M | |
Retained Earnings | 5.0B | 5.0B | 5.2B | 4.7B | 4.5B | 3.0B | |
Accounts Payable | 61.9M | 69.3M | 48.8M | 121.4M | 90.6M | 51.7M | |
Cash | 1.6B | 1.6B | 2.8B | 2.7B | 2.9B | 3.1B | |
Non Current Assets Total | 35.6B | 35.4B | 35.0B | 35.1B | 34.8B | 24.0B | |
Non Currrent Assets Other | 2.1B | 2.0B | 3.3B | (3.1B) | 3.2B | 3.4B | |
Other Assets | 545.9M | 7.3B | 3.3B | 574M | 134.4M | 127.7M | |
Long Term Debt | 3.7B | 3.4B | 2.7B | 3.4B | 3.4B | 2.5B | |
Cash And Short Term Investments | 1.6B | 1.7B | 2.9B | 2.8B | 3.0B | 2.7B | |
Net Receivables | 491.8M | 461.3M | 434.5M | 483.2M | 535.6M | 308.3M | |
Common Stock Shares Outstanding | 358.2M | 358.5M | 358.9M | 359.2M | 359.5M | 311.9M | |
Liabilities And Stockholders Equity | 75.2B | 124.7B | 196.8B | 174.2B | 129.7B | 136.2B | |
Non Current Liabilities Total | 10.5B | 10.1B | 9.0B | 9.6B | 9.6B | 7.4B | |
Other Current Assets | 360.1M | 302M | 158.4B | 135.8B | 91.3B | 95.9B | |
Other Stockholder Equity | 21.1B | 16.2B | 22.2B | 22.3B | 22.3B | 14.3B | |
Total Liab | 49.1B | 98.3B | 169.4B | 147.3B | 103.0B | 108.1B | |
Property Plant And Equipment Gross | 544M | 579.2M | 505.3M | 455.5M | 1.3B | 1.4B | |
Total Current Assets | 39.6B | 89.3B | 161.8B | 139.1B | 94.9B | 99.6B | |
Accumulated Other Comprehensive Income | 3.4M | 134.9M | 53.5M | (133.3M) | (55.6M) | (52.8M) | |
Property Plant Equipment | 544M | 579.2M | 505.3M | 837.6M | 963.2M | 490.1M | |
Short Term Investments | 83.2M | 100.9M | 115M | 96M | 111.7M | 106.1M | |
Inventory | 37.1B | 86.8B | 158.0B | 135.3B | 94.9B | 99.6B | |
Short Term Debt | 49.7M | 52.2M | 749.4M | 74.1M | 55.1M | 52.3M | |
Intangible Assets | 22.3B | 22.0B | 20.7B | 20.4B | 20.2B | 18.4B | |
Good Will | 10.7B | 10.8B | 10.5B | 10.5B | 10.5B | 8.9B | |
Retained Earnings Total Equity | 4.9B | 5.0B | 5.0B | 5.2B | 5.9B | 3.7B | |
Deferred Long Term Liab | 5.7B | 5.6B | 5.6B | 5.4B | 6.2B | 4.7B | |
Net Tangible Assets | (6.9B) | (6.5B) | (3.8B) | (4.0B) | (4.7B) | (4.9B) | |
Long Term Debt Total | 3.8B | 3.7B | 3.4B | 2.7B | 3.1B | 2.9B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether CME Group is a strong investment it is important to analyze CME's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CME's future performance. For an informed investment choice regarding CME Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Financial Exchanges & Data space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CME. If investors know CME will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CME listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.214 | Dividend Share 4.55 | Earnings Share 9.64 | Revenue Per Share 16.795 | Quarterly Revenue Growth 0.185 |
The market value of CME Group is measured differently than its book value, which is the value of CME that is recorded on the company's balance sheet. Investors also form their own opinion of CME's value that differs from its market value or its book value, called intrinsic value, which is CME's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CME's market value can be influenced by many factors that don't directly affect CME's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CME's value and its price as these two are different measures arrived at by different means. Investors typically determine if CME is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CME's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.